[Analysis of alveolitis (pneumonitis) as a complication of cytostatic (CMF) therapy].
D000971:Antineoplastic Combined Chemotherapy Protocols; D001943:Breast Neoplasms / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects; D011014:Pneumonia / Q000139:chemically induced*; D011650:Pulmonary Alveoli / Q000187:drug effects; D011658:Pulmonary Fibrosis / Q000139:chemically induced
D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate
Cytostaticus kezelések (CMF) szövödményeként kialakuló alveolitisek (pneumonitisek) vizsgálata.